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Summary
Our knowledge of the transformation process has emerged largely from studies of primary rodent cells and animal models.
However, numerous attempts to transform human cells using oncogene combinations that are effective in rodents have
proven unsuccessful. These findings strongly argue for the study of homologous experimental systems. Here we report
that the combined expression of adenovirus E1A, Ha-RasV12, and MDM2 is sufficient to convert a normal human cell into
a cancer cell. Notably, transformation did not require telomerase activation. Therefore, we provide evidence that activation
of telomere maintenance strategies is not an obligate characteristic of tumorigenic human cells.
Introduction O’Brien et al., 1986; Stevenson and Volsky, 1986; Serrano et
al., 1997).
Two major hypotheses have emerged as the underlying ex-Neoplastic transformation occurs via a series of genetic and
planation for such differences. Primary human and murine cellsepigenetic alterations that yield a cell population that is capable
respond to oncogene activation via homeostatic mechanismsof proliferating independently of both external and internal sig-
that are proposed to enforce tumor suppression. For example,nals that normally restrain growth. For example, transformed
activation of oncogenes such as c-myc or adenovirus E1A sensi-cells show reduced requirements for extracellular growth pro-
tizes primary cells to apoptosis (Debbas and White, 1993; Lowemoting factors, are not restricted by cell-cell contact, and are
et al., 1994; Lowe and Ruley, 1993; Harrington et al., 1994;often immortal (Paulovich et al., 1997; Hanahan and Weinberg,
Hermeking and Eick, 1994). Hyperactivation of the ras oncogene2000). Through extensive studies of transformation processes
or flux through the ras signaling pathway induces a state of
in rodent models, it is known that tumor formation can be
terminal growth arrest which is phenotypically similar to cellular
achieved by the activation of oncogenes and the inactivation senescence (Serrano et al., 1997). In murine cells, the latter
of tumor suppressor pathways (Paulovich et al., 1997; Hanahan response can be bypassed by genetic alterations, which impair
and Weinberg, 2000; Sherr, 1996). It has long been established the p53 response. Indeed, cells lacking p53 or p19ARF can be
that primary rodent cells can be transformed at detectable fre- transformed directly by activated ras (Kamijo et al., 1997; Ser-
quency by two oncogenic “hits,” such as the combination of rano et al., 1996, 1997). In contrast, inactivation of the p53
ectopic c-myc expression and constitutive activation of Harvey pathway alone is insufficient to rescue human cells from ras-
Ras (Ha-RasV12) (Land et al., 1983; Ruley, 1983). However, induced growth arrest (Serrano et al., 1997), suggesting that
primary human cells have proven to be refractory to transforma- homeostatic responses in humans flow through multiple inde-
tion by numerous combinations of cellular and viral oncoprot- pendent and redundant effector pathways.
eins, indicative of fundamental differences in requirements for A second characteristic that distinguishes primary human
and murine cells is that the latter are easily immortalized (Blascotransformation in human versus rodent cells (Sager, 1991;
S I G N I F I C A N C E
Activation of telomerase, and consequently telomere maintenance, is a common characteristic of human tumors. Existing models
of human cancer cells, created by the introduction of defined genetic alterations, all include telomerase activation and/or telomere
maintenance as an obligate component of the transformed phenotype. Here, we demonstrate that normal human cells can be
converted into cancer cells, capable of forming tumors in immunocompromised mice, in the absence of telomerase activation or
an alternative telomere maintenance strategy. This suggests that alterations in telomere biology must be viewed similarly to genomic
instability as catalysts of transformation rather than as central components of the transformed phenotype.
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et al., 1997a). Primary human cells rarely undergo spontaneous the adenovirus oncogene, E1A (Figure 1A) (Serrano et al., 1997;
de Stanchina et al., 1998). In fact, coexpression of E1A and Ha-immortalization, indicating that the control of cellular lifespan is
RasV12 provided one of the first demonstrations of transforma-drastically different between these two cell types (Imam et al.,
tion by cooperating oncogenes in primary rodent cells (Ruley,1997; Chin et al., 1999). This phenomenon can be partially attrib-
1983). Therefore, we tested whether combined expression ofuted to telomere biology. Unlike the embryonic rodent fibro-
E1A and Ha-RasV12 could transform normal human primaryblasts which have served as common models for studies of
fibroblasts.transformation in vitro, primary human fibroblasts have relatively
One characteristic feature of transformed cells is their abilityshort telomeres and lack detectable telomerase activity (re-
to grow in the absence of anchorage and, therefore, form colo-viewed in McEachern et al., 2000).
nies in semisolid media. Early passage normal human foreskinThe importance of telomerase in human tumorigenesis is
fibroblasts (designated BJ) expressing E1A or Ha-RasV12 indi-supported by numerous observations. First, the majority of hu-
vidually failed to form colonies in soft agar. In contrast, cellsman tumors are telomerase-positive (Kim et al., 1994). Second,
expressing both E1A and Ha-RasV12 were able to form coloniestelomerase activation is sufficient to immortalize some primary
in soft agar with an efficiency comparable to that seen withhuman cells in culture (Bodnar et al., 1998; Counter et al., 1998;
transformed human and rodent cells (Figure 1B). For humanWang et al., 1998). Third, telomerase is regulated by an onco-
293T cells, virtually all plated cells gave rise to colonies, com-
gene, c-myc, which is activated in a high percentage of human
pared to a range of 10%–30% for BJ/E1A/Ha-RasV12 (for exam-
cancers (Wang et al., 1998). ple, see Figure 1C). In general, colonies generated by BJ/ER
Previous reports have indicated that primary human fibro- (EE1A, RHa-RasV12) contain significantly fewer cells than
blasts and epithelial cells can be transformed by a defined com- those generated by 293T cells within the same time period.
bination of genetic elements, comprising the telomerase cata-
lytic subunit, hTERT, the SV40 early region, and Ha-RasV12 The role of E1A in the transformation of primary
(Hahn et al., 1999; Elenbaas et al., 2001, Hahn et al., 2002). Here human fibroblasts
we report an alternative model of human cell transformation. We E1A is a multifunctional protein that interacts with numerous
show that coexpression of two oncogenes, adenovirus E1A and cellular proteins involved in controlling proliferation. For exam-
Ha-RasV12, is sufficient to enable primary human fibroblasts ple, E1A can bind members of the Rb family through conserved
to grow in an anchorage-independent manner, a hallmark of in motifs designated CR1 and CR2 (Whyte et al., 1988; Harlow et
vitro transformation. However, this combination is insufficient al., 1986; Whyte et al., 1989). Through these interactions, E1A
to promote tumor formation in nude mice. Addition of a third is able to modulate the activity of the E2F family of transcription
oncogene, MDM2, can convert these fibroblasts into cells capa- factors, thus controlling genes required for entry into S phase
(Wang et al., 1995; Paulovich et al., 1997; Sherr, 1996). Theble of forming tumors in vivo. Interestingly, both anchorage-
amino-terminus of E1A binds promiscuous transcriptional co-independent growth in vitro and tumorigenesis in vivo occur in
activators, including p300 (Dorsman et al., 1995; Wang et al.,the absence of telomerase activation. Our results indicate that
1995; Goodman and Smolik, 2000). The amino-terminus alsowhile telomerase activation is a common characteristic of hu-
binds to the protein complex containing p400, a SWI2/SNF2man tumors, it is not an obligate element of the tumorigenic
family member, and the c-Myc/pCAF-interacting protein,phenotype.
TRRAP (McMahon et al., 1998; Barbeau et al., 1994, Fuchs et
al., 2001). This p400 binding region has been shown to be vitalResults
for E1A-mediated transformation in mouse cells (Fuchs et al.,
2001). The carboxy-terminal region of E1A binds CtBP, a cellularCoexpression of E1A and Ha-RasV12 permits
protein, which has been proposed to recruit histone deacety-anchorage-independent growth
lases (Goodman and Smolik, 2000).A defining characteristic of the transformed phenotype is a de-
In order to map the regions and interactions of E1A that aregree of independence from exogenous mitogenic signals. Many
essential for its ability to cooperate with Ha-RasV12 in conferring
of these signals activate the ras pathway, and activating muta-
anchorage-independent growth to primary human fibroblasts,
tions of ras oncogenes or their upstream regulators often occur we used a series of well-characterized deletion mutants for in
in human cancers (Barbacid, 1987; Webb et al., 1998). However, vitro transformation assays (Samuelson and Lowe, 1997). Cells
in both primary rodent and human cells, expression of the ras were coinfected with Ha-RasV12 and mutant E1A oncoproteins.
oncogene alone results in an irreversible growth arrest that is While a truncated E1A protein consisting of only the amino-
phenotypically similar to cellular senescence (Serrano et al., terminal 143 amino acids is unable to bind CtBP (Boyd et al.,
1997; Lin et al., 1998). In rodent models, c-myc is capable of 1993; Meloni et al., 1999), this mutant is capable of cooperating
both bypassing ras-induced growth arrest and cooperating with with Ha-RasV12 for colony formation in soft agar with high
activated Ha-RasV12 to transform primary cells into tumorigenic efficiency (Figure 2). Expression of E1A-CR2, a mutant incapa-
cells (Land et al., 1983). However, combined expression of myc ble of binding pRb (Samuelson and Lowe, 1997), in combination
and activated ras in normal human cells not only fails to result with Ha-RasV12 invariably led to a senescence-like growth ar-
in transformation, but also leads to an accelerated appearance rest. This result indicated that the interaction between E1A and
of the senescent-like phenotype (data not shown). Rb-family proteins is essential for transformation. Loss of the
Whereas numerous genetic alterations have been shown to ability to bind p300 also compromised oncogene cooperation,
bypass ras-induced growth arrest in murine cells, only very few as did deletion of residues 26–35, indicating that the ability to
have been shown to be capable of overriding this response in bind p400 is also critical. Western analysis of E1A mutants
(Supplemental Figure S1 at http://www.cancercell.org/cgi/normal human cells. One of these is the ectopic expression of
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Figure 1. Transformation of normal human fibro-
blasts by E1A and Ha-RasV12
A: Normal human diploid fibroblasts (BJ) infected
with a recombinant retrovirus that directs expres-
sion of Ha-RasV12 stain positively for expression
of the senescence-associated -galactosidase
marker, whereas BJ fibroblasts coinfected with
retroviruses for E1A (12s) and Ha-RasV12 expres-
sion do not stain for this marker and continue to
proliferate.
B: BJ fibroblasts were infected with retroviruses
for E1A or Ha-RasV12 expression alone or in com-
bination and assayed for colony formation in
semisolid media.
C: Colonies containing greater than 100 cells
were counted from triplicate platings of cells with
the indicated genotype to determine the rate
of colony formation. Standard error from the
mean is indicated.
content/full/2/5/401/DC1) suggested that each was expressed subcutaneous injection into immunocompromised mice. A total
of 49 animals were injected in both flanks in a series of fivesimilarly to wild-type, and thus the defects in colony formation
independent experiments. Subject mice were either nude, SCIDwere not due to E1A not being adequately expressed. Expres-
(beige), or nude mice that had been irradiated as a mean tosion of E1A-CR2 mutant was confirmed only in transient infec-
suppress residual NK (natural killer) responses (Feuer et al.,tions, since the prevalence of cell death in CR2/Ras coinfected
1995). From a total of 98 injections, only a single tumor formedcells prevented the establishment of a stable cell line. Consid-
in a nude, nonirradiated mouse (Supplemental Table S1 at http://ered together, these results suggest that E1A functions in human
www.cancercell.org/cgi/content/full/2/5/401/DC1). This tumorcell transformation through concerted effects on multiple cellular
arose after a substantially longer latency (10 weeks) than ispathways that include Rb, p300, and p400.
normally observed using control cancer cell lines or transformed
human 293T cells (2 weeks), suggesting the possibility that aE1A  Ha-RasV12-expressing cells fail to form tumors
Early and late passage BJ fibroblasts coexpressing E1A and rare additional genetic alteration may have contributed to tumor
formation in this individual case. Thus, we conclude that whileHa-RasV12 were tested for the ability to form tumors upon
Figure 2. Functional analysis of the regions of E1A
required for transformation in vitro
A series of well-characterized functional mutants
of E1A were coexpressed in BJ fibroblasts with
Ha-RasV12 and assayed for the ability to form
colonies in semisolid media. Only the E1A-143
mutant, which is defective for the ability to bind
CtBP, was capable of forming colonies in this
assay, indicating that the ability of E1A to bind
p300, p400, and Rb is critical for E1A-mediated
transformation.
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the combination of E1A and Ha-RasV12 is sufficient to permit
anchorage-independent growth of normal human fibroblasts,
this combination is insufficient for tumorigenesis in nude mice.
E1A, MDM2, and Ha-RasV12 transform normal human
cells into tumor cells
Previous studies of E1A/Ha-RasV12-mediated transformation
in primary mouse embryo fibroblasts (MEF) indicated that trans-
formation mediated by this oncogene combination was much
more efficient in the absence of p53 (Lowe and Ruley, 1993).
In fact, tumors arising from E1A/Ras transformed MEF become
apparent only after a long latency period and frequently lack
a functional p53 pathway. Interestingly, immunohistochemical
analysis of the single tumor produced by the BJ fibroblasts
expressing E1A/Ha-RasV12 showed a strong accumulation of
nuclear p53; however, results of SSCP analysis excluded the
possibility of p53 gene mutations (data not shown).
Accumulation of wild-type p53 is a common feature of hu-
man sarcoma, the type of tumor derived from fibroblast precur-
sors. In addition, these tumors often show overexpression of
MDM2 (Dei Tos et al., 1997), indicating that negation of p53
function occurs often through mechanisms other than p53 gene
mutation. Notably, the tumor that resulted from the E1A/
Ha-RasV12-expressing fibroblasts was negative for the expres-
sion of p19ARF, an upstream regulator of MDM2 (by immunohisto-
chemistry, data not shown), whereas the preinjection population
of engineered fibroblasts expressed p19ARF abundantly. Guided
by these observations, we tested whether negation of the p53
pathway via enforced expression of MDM2 could contribute to
the transformation of normal human fibroblasts by E1A and Ha-
RasV12.
BJ cells at different passage numbers (see Experimental
Figure 3. MDM2 cooperates with E1A and Ha-RasV12 to enhance colonyProcedures for details) were simultaneously coinfected with
formation in vitrothree retroviruses that direct the expression of E1A, Ha-RasV12,
A: BJ fibroblasts were infected with retroviruses to direct the expression ofand MDM2 with each retrovirus bearing a different drug selec-
three genes, E1A (E), Ha-RasV12 (R), and MDM2 (M), alone and in combina-tion marker. Control cells were prepared by replacing individual
tion, and plated into semisolid media. Notably, cells engineered to express
oncogene-expressing viruses with an empty vector bearing the all three genes simultaneously (ERM) formed robust colonies similar to those
same selection marker. These triple-infected populations were produced in the 293T control.
B: Colonies containing greater than 100 cells were counted from triplicatesimultaneously coselected with puromycin, hygromycin, and
platings of cells with the indicated genotype in order to determine the rateneomycin for ten days and then either plated into soft agar
of colony formation. The standard error from the mean is indicated. ERM
(Figure 3) or injected into immunocompromised mice (Figure 4). cells form colonies at a rate greater than ER cells and more comparable
Expression of the ectopically expressed oncogenes was con- to the control 293T cell line.
firmed by Western blot (not shown). Cell populations expressing
E1A/Ha-RasV12/MDM2 formed colonies in soft agar with higher
efficiency than BJ/E1A/Ha-RasV12 (Figure 3B). Moreover, the
triple-infected cells were able to generate tumors when injected blotting analysis (Supplemental Figure S2 at http://www.cancercell.
subcutaneously into immunocompromised in mice (Figure 4A org/cgi /content/ fu l l /2/5/401/DC1) . These results argue
and Table 1). Tumors grew to a size at which the animals had against the possibility of selection for rare genetic events during
to be sacrificed within a period of three to six weeks after tumor formation and support the notion that the combined ex-
injection, a latency comparable to that seen with control human pression of E1A, MDM2, and Ha-RasV12 is sufficient for the
cancer cell lines or with transformed 293T cells (Figure 4B). transformation of normal human fibroblasts into tumor cells.
Tumor formation was also observed when E1A was substituted
by the C-terminal deletion mutant E1A-143 (data not shown). Human fibroblasts transformed by E1A/MDM2/Ha-RasV12
Histological and immunohistochemical analyses of ERM- lack telomerase activity
derived tumors confirmed the human origin of the tumor cell Cell immortalization has been posited as a landmark occurrence
population and indicated that the neoplasias have features of in the transformation of a normal cell into a cancer cell. Indeed,
sarcoma. Moreover, immunohistochemistry confirmed the most human cancers are telomerase-positive, an indirect indica-
tion that these cells have acquired a mechanism for both telo-widespread and strong expression of E1A, Ras, and MDM2
oncogenes (Figure 4C). mere maintenance and extension of proliferative capacity (Kim
et al., 1994). In previous reports, transformation of normal hu-Cell populations remained polyclonal throughout drug selec-
tion in vitro and tumorigenesis in vivo, as revealed by Southern man cells absolutely required activation of telomerase via ex-
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Table 1. Formation of subcutaneous tumors in nude mice by human
fibroblasts expressing E1A, Ha-RasV12, and MDM2
Tumor formation in immunodeficient mice: E1A  MDM2 
Ha-RasV12
Number tumors/
Cells number injected
293T 6/6
BJ 0/10
BJ/E1A  Ha-RasV12 0/6
BJ/E1A  MDM2 0/5
BJ/E1A  MDM2  Ha-RasV12 34/48
BJ/E1A-143  MDM2  Ha-RasV12 6/6
Tumor formation: Additional human fibroblast strains
Number tumors/
Cells number injected
BJ/E1A  MDM2  Ha-RasV12 12/12
HSF43/E1A  MDM2  Ha-RasV12 2/8
WI-38/E1A  MDM2  Ha-RasV12 7/8
Detroit551/E1A  MDM2  Ha-RasV12 7/7
For each injection, 5  106 cells of the indicated populations were injected
subcutaneously in a volume of 100l. Mice were sacrificed when the tumors
reached a diameter of 1 to 1.2 cm or after 16 weeks of monitoring. The
top and bottom portions of the table represent two independent series of
experiments.
ized by dramatically reduced proliferation and adoption of aFigure 4. Conversion of BJ fibroblasts into tumor cells by combined expres-
sion of E1A, Ha-RasV12, and MDM2 senescent phenotype. Few BJ/ERM cells eventually survive this
phase, and these cells become telomerase-positive (Figure 5A,A: Examples of immunocompromised mice (nude, no  irradiation) that
have been injected with either control BJ fibroblasts or BJ cells that have ERM P.C.). This behavior is suggestive of a “telomere crisis”
been engineered to express E1A (E), Ha-RasV12 (R), and MDM2 (M). as a consequence of the absence of a telomere maintenance
B: Tumor growth rates from two representative mice (ERM-1662 and ERM-
program. This hypothesis is supported by an examination of1521) injected in both flanks (a, left; b, right) with BJ/ERM fibroblasts are
telomere dynamics in BJ/ERM cells. Telomeres shrink continu-compared to tumor growth rates in a mouse that had been injected in
both flanks with E1A-expressing 293T cells, as indicated. ously as cells are passaged in culture, reaching an average
C: Immunohistochemistry staining of ERM tumor samples with antibodies to length of 3 kb prior to entering a crisis phase from which the
E1A, Ha-Ras, and MDM2, verifying that the tumors were in fact derived from
population emerges with detectable telomerase activity (Figuresthe injected cells
6A and 6B).
Tumors derived from E1A/MDM2/Ha-RasV12 lack
telomerase activitypression of the limiting catalytic subunit, hTERT (Hahn et al.,
Since ERM-engineered fibroblasts were telomerase-negative at1999; Elenbaas et al., 2001, Hahn et al., 2002). We previously
the time of injection into mice, we were curious to ascertain theshowed that E1A, Ha-RasV12, and MDM2 were individually
telomerase status of resultant tumors and to determine whetherincapable of activating telomerase in normal human fibroblasts
telomerase activation was a requirement for tumorigenesis. Te-or epithelial cells (Wang et al., 1998). We therefore tested the
lomerase activity was measured utilizing the standard TRAPpossibility that we had transformed normal human cells into
assay described above on tissue sections obtained from thecancer cells in the absence of telomerase activation.
ERM tumors. Whereas a tissue sample from a human tumorTelomerase activity was easily detected in 293T cells using
produced a robust signal indicative of telomerase activity in athe TRAP assay (Kim et al., 1994; Wright et al., 1995). As few
TRAP assay, lysates from ERM tumor tissues were telomerase-as ten 293T cells were capable of yielding a strong positive
negative (Figure 5B). In order to verify that this negative resultsignal in our assays. As expected, BJ fibroblasts are telomerase-
was not due to the presence of an inhibitory component withinnegative. We similarly fail to detect telomerase activity in BJ
the tissue lysate, we performed a mixing experiment with lysatecells that have been engineered to express E1A, Ha-RasV12,
from 293T cells. When the 293T cell and ERM tumor lysates wereand MDM2 (BJ/ERM) (Figure 5A). We conclude that BJ/ERM
mixed in a TRAP reaction, the result was positive, indicating thatcells are telomerase-negative, or contain at least 1000-fold less
there was no inhibitory component within the tumor lysate, andtelomerase activity than do 293T cells at the time they are in-
thus the tumors were below detectable limits for telomerasejected into immunocompromised mice.
activity (Figure 5B).It is interesting to note that BJ/ERM cells, although able to
To verify the forgoing result, we used an independent experi-form colonies in soft agar and tumors in nude mice, are not
mental strategy. In human cells, and in particular in humanimmortal and, if maintained in culture for an extended period
of time (40–50 generations), undergo a “crisis phase” character- fibroblasts such as BJ, telomerase activity correlates with the
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Figure 5. BJ/ERM cells are telomerase-negative
upon injection into nude mice
A: The TRAP assay was used to detect telomerase
activity in uninfected BJ cells and BJ/ERM cells
at various passages. At the time of injection
(p20), ERM cells are telomerase-negative. How-
ever, after continuous passaging in culture, these
cells undergo an event similar to crisis, a point at
which many cells undergo apoptosis or senes-
cence. Cells that emerged from this crisis event
become telomerase-positive (ERM P.C.). The in-
dicated protein concentrations (g) of S-100 ex-
tract were used. The highest protein concentra-
tion, 2.3 g, was also pretreated with RNase (R)
as a negative control.
B: Tumors were recovered from mice injected
with BJ/ERM cells and assayed for the presence
of telomerase activity using the TRAP assay. To
test whether tissue extracts contained inhibitors
of any step of the procedure, we mixed lysate derived from 1,000 telomerase-positive 293T cells with the tumor extract. This produced a positive signal.
The figure shows one representative tumor sample. For comparison, a similar telomerase assay performed using a mass-equivalent portion of lysate from
a human breast tumor is shown.
C: RT-PCR was used to detect hTERT expression in BJ-ERM-derived tumors (tumors 1521, 1662, and 1659; left, sn; right, dx). Expression was tested by using
two primer pairs that would direct the specific amplification of hTERT and not mouse TERT that might be present from contaminating murine cells within
the tissue sample. -actin served as an internal control. Sensitivity of the assay was increased by performing a Southern blot of the PCR reactions for hTERT.
293T, DLD colon cancer, and BL41 lymphoma cell lines were used as positive controls. 293T 1:100 represents the PCR product of 293T cell line diluted 1:100,
in order to have an approximate quantification of the signal. The figure shows the result of 40 cycles of amplification for hTERT and 20 cycles for -actin.
expression of the telomerase catalytic subunit, hTERT (Meyer- present from contaminating murine cells in the tumor sample.
son et al., 1997; Bodnar et al., 1998). We used an RT-PCR -actin mRNA served as an internal control. Ethidium bromide
strategy to search for hTERT expression in BJ/ERM tumor speci- gel staining showed that hTERT mRNA was easily detectable
mens. Expression was tested using two independent primer in RNA derived from human cancer cell lines, but BJ/ERM tu-
pairs that were chosen for their ability to specifically amplify mors were negative (Figure 5C). To increase the sensitivity of
human TERT without amplifying mouse TERT that might be our assay, we performed Southern blots of the PCR reactions.
After Southern analysis, one out of six tumors analyzed, sample
1659sn, showed weak hTERT expression. This signal was de-
tectable only with an exposure at which the signal of the positive
control cells had reached saturation. The expression of hTERT
in this tumor was independently confirmed by increasing the
number of PCR cycles to 50 (see Figure 9B). Considered to-
gether, these data suggest that BJ/ERM cells were competent
for tumor formation in the absence of telomerase activity and
that activation of telomerase can occur as a late event during
tumor progression.
Upon explantation into culture, BJ/ERM tumor cells, similar
to late passage ERM, undergo a crisis event, which is marked
by cellular senescence and apparent cell death. In contrast,
explantation of tumors generated with 293T control cells did
not produce a similar outcome. Instead, these cells proliferate
robustly. Following this crisis event, few BJ/ERM tumor cells
emerge to form a sustainable population. In contrast to early
passage BJ/ERM cells and to BJ/ERM tumor samples, and
similar to postcrisis late passage BJ/ERM, surviving tumor cellsFigure 6. Telomere dynamics in ERM-transformed cells before and after tu-
mor explant have become telomerase-positive (Figure 6A). The forgoing is
suggestive of a “telomere crisis” possibly related to the lack ofA: The TRAP assay was used to detect telomerase activity in cells explanted
from ERM tumors and compared to ERM cells that had been in continuous a telomere maintenance program in the tumor mass, a crisis
culture. The explanted cell lines (1662dxp8, 1662snp18, and 1731snp9) were that could be compensated by an in vitro selection of a cell
telomerase-positive, similar to what was seen in ERM cells that had been
population with activated telomerase.continuously passaged in culture until they underwent crisis (ERM P.C.).
In accord with this hypothesis, TRF assays and telomericB: Telomere length in uninfected BJ, BJ/ERM, and ERM tumor explants were
analyzed by TRF using pulse-field electrophoresis. As predicted, the telo- FISH confirmed that continuous telomere erosion occurred dur-
meres of uninfected BJ and BJ/ERM become shorter as the cells are pas- ing transformation in vitro and tumor formation in vivo (Figures
saged in vitro. Interestingly, the telomeres of both ERM P.C. and explanted
6B and 7). Telomeres in early passage BJ cells averaged 7cell lines (1662dxp8, 1662snp18, and 1731snp9) had become extremely short
irrespective of the fact they were telomerase-positive. kb in length. These became depleted as BJ cells were engi-
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Figure 7. Quantitative FISH analysis of ERM cells preinjection and postexplant
A: Telomere length distribution of BJ, BJ/ERM, and BJ/ERM tumor cells at different passages as determined by quantitative FISH (Q-FISH) using a fluorescent
Cy-3 labeled telomeric peptide nucleic acid (PNA) probe. Average telomere length in kbps and standard deviation, as well as the total number of
telomeres analyzed for each cell culture, are indicated. The percentage of undetectable telomeres using Q-FISH is also indicated.
B: Representative Q-FISH images of metaphases from BJ, BJ/ERM, and BJ/ERM tumor cells hybridized with a telomeric PNA probe. We note a significant
decrease in telomeric signal, as well as the increased chromosomal instability and increased aneuploidy in later passage ERM cells and in BJ/ERM tumor-
derived cells, 1662sn. Blue: DAPI; yellow dots: telomeres.
neered to express oncogenes and were passaged in vitro to an The karyotypes of explanted BJ/ERM cells reveal
chromosomal abnormalities characteristicaverage of 5 kb at passage 20 and 3.1 kb in BJ/ERM after crisis
of telomere depletionoccurred in vitro. Consistent with an apparent lack of a telomere
As noted above, BJ cells are engineered to express E1A, Ha-maintenance strategy, telomere depletion continued during tu-
RasV12, and MDM2 through simultaneous coinfection. Sincemor formation in vivo such that explanted cell cultures had
these cells have not undergone prolonged expansion in theextremely short telomeres, averaging 1.6 kb with 18% of chro-
presence of any individual oncogene in culture, it is not surpris-mosome ends lacking detectable telomeric DNA (Figure 7).
ing to find that the karyotypes of the engineered cells are normalThese results rule out the possibility that BJ/ERM tumors have
prior to injection into mice (Supplemental Figure S3A at http://
activated the recombination-based pathways of telomere main-
www.cancercell.org/cgi/content/full/2/5/401/DC1). Examina-
tenance (ALT) (Dunham et al., 2000; Bryan and Reddel, 1997; tion of cells that are explanted into culture following tumor for-
Hoare et al., 2001; Bryan et al., 1997). Interestingly, cells ex- mation, however, reveals numerous chromosomal abnormalities
planted from ERM tumors that had become telomerase-positive (Figure 8, Supplemental Table S2, and Supplemental Figure
in vitro (Figure 6A) maintained their ability to form tumors in S3B). In virtually every metaphase, we noted the presence of
nude mice and did so at rates similar to those observed for dicentric chromosomes lacking telomeres at the fusion point
that apparently formed via end-to-end fusion of TTAGGG-primary ERM cells (data not shown).
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Figure 8. Comparative karyotype analysis of BJ,
BJ/ERM, and BJ/ERM tumor-derived cells
A: Karyotype analysis of BJ, BJ/ERM, and BJ/ERM
tumor cells at different passages is shown. For
each culture, 15 metaphases were evaluated.
Notice that the tumor-derived cells were se-
verely aneuploid compared with BJ cells at two
different passages. ERM p20 and ERM P.C. cells
show a modest aneuploidy.
B: Representative images of cytogenetic alter-
ations detected in metaphases from BJ/ERM ex-
planted tumor cells after staining with DAPI and
a fluorescent Cy-3-labeled telomeric PNA probe.
TRANS, translocation; DICENT, dicentric; TRICENT,
tricentric; blue, chromosome DNA stained with
DAPI; yellow and white dots, TTAGGG repeats.
depleted telomeres. In some metaphases, we also find ring pendent growth and tumor formation (see Experimental Proce-
dures for details). In all the conditions tested, both early andchromosomes (Supplemental Figure S3B). In addition, these
cells showed a very marked aneuploidy as indicated by aberrant late passage BJ/ERM invariably produced colonies in soft agar
and tumors in immunocompromised mice.number of chromosomes in more than 50% of the metaphases
analyzed, also in agreement with aberrant mitosis as a conse- Finally, to verify that E1A/MDM2/Ha-RasV12-mediated
transformation is not unique to BJ fibroblasts, we assessed thequence of severe telomeric dysfunction (Figure 8). These types
of genetic abnormalities are a characteristic outcome of telo- validity of our transformation model in several additional human
primary fibroblasts, including HSF43, WI-38, Detroit 551, andmere depletion and are similar to those seen in the karyotypes
of Terc/ mice (Blasco et al., 1997b; Nanda et al., 1995). Con- SF68 as well as in human primary mesodermal cells, HMSC.
Upon coexpression of E1A/MDM2/Ha-RasV12, all were capablesidered together, the results of telomerase detection assays,
telomere restriction fragment analyses, and cytogenetic exami- of anchorage-independent growth in soft agar (not shown). Ef-
ficiencies of colony formation and rates of colony growth werenation of explanted tumor cells strongly suggest that combined
expression of E1A, Ha-RasV12, and MDM2 is capable of trans- similar to those seen with BJ/ERM cells. Furthermore, these
triple-infected fibroblasts were capable of tumor formation whenforming normal human cells into human tumor cells in the ab-
sence of direct telomerase activation or alternative mechanisms injected into immunocompromised mice (Table 1 and Figure
9A). Similar to BJ/ERM, HSF43/ERM, WI-38/ERM, and DET551/of telomere maintenance.
ERM fibroblasts were telomerase-negative and the majority of
the tumors derived from these cells failed to show telomeraseMultiple human primary fibroblasts can be transformed
by coexpression of E1A/MDM2/Ha-RasV12 expression by hTERT-RT-PCR analysis. Only 2 out of 8 tumors
tested showed a faint hTERT band following 50 cycles of ampli-In order to ascertain whether the transforming potential of the
ERM combination relied on the relatively long telomeres found fication (Figure 9B). This confirms that also in HSF43, WI-38,
and DET551 fibroblasts, the ERM combination does not requirein early passage BJ fibroblasts, populations of cells at different
passage numbers were infected and tested for anchorage-inde- telomerase activation to confer tumorigenic potential.
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Figure 9. Multiple human fibroblast strains can be
transformed in the absence of direct telomerase
activation
A: Examples of immunocompromised mice
(nude, no  irradiation) injected with control fi-
broblasts expressing E1A  Ha-RasV12 or fibro-
blasts engineered to express the oncogene
combination of E1A  Ha-RasV12  MDM2. As
had been seen with BJ fibroblasts, additional hu-
man primary fibroblasts (HSF43, WI-38, and De-
troit551) became tumorigenic upon expression
of the combination of ERM, while the combina-
tion of ER alone was unable to result in tumori-
genesis.
B: RT-PCR analysis for hTERT expression in BJ, De-
troit551, HSF-43, and WI-38 primary cells ex-
pressing E1A  Ha-RasV12  MDM2 (left panel).
RT-PCR analysis for hTERT expression in BJ/ERM
tumors (1659 and 1857), Det-551/ERM tumors
(1850, 1854), HSF-43/ERM tumors (1733 left and
right tumor), and WI-38/ERM tumors (1852 and
1853 left and right tumor) (right panel). BL41
and DLD1 cell lines were used as positive con-
trols. The figure shows the result of 50 cycles of
amplification for hTERT and 20 cycles for -actin.
Discussion One striking difference between our results and those re-
ported previously is that in our transformation model, we find
Primary rodent cells and animal models have made invaluable no requirement for telomerase activation to achieve either an-
contributions to our understanding of neoplastic transformation chorage-independent growth in vitro or tumor formation in vivo.
and of the biology of oncogenes and tumor suppressors. How- In fact, consistent with their lack of telomerase or other telomere
ever, it is clear that these models do not perfectly recapitulate maintenance strategies, our in vitro-engineered tumor cells
the process of tumor development in humans. An early indica- show continuous erosion of telomeric repeats. This ultimately
tion of this fact was the inability of human cells to become leads to genetic instability that is typified by our observation of
transformed by the same combinations of oncogenes that could numerous chromosome end-to-end fusions and pronounced
transform a variety of normal rodent cells. Recently, the ability aneuploidy in cells explanted from tumor tissue.
to elicit transformation via specific genetic manipulations was The majority of human cancer cells are reported to be telo-
extended to normal human cells (Hahn et al., 1999; Elenbaas merase-positive (Kim et al., 1994), and this is long been consid-
et al., 2001, Hahn et al., 2002). This has created the opportunity ered a strong indication that the ability to maintain telomeres
for the development of a variety of defined human cancer mod- is an important step in the development of human cancer. How-
els to be used for a detailed study of the cellular pathways that ever, it is still debated whether the widespread presence telo-
are required for the transformation of normal human cells, and merase activity in human tumors is a reflection of a selective
ultimately, to an understanding of any differences in require- expansion of a telomerase-positive stem cell or a selection for
ments for the transformation of human cells versus those of a mechanism of telomere maintenance during cancer pro-
model organisms. Such information could provide critical in- gression.
sights as rationally designed anticancer therapies move from Our results are consistent with a model in which telomere
successful applications in animal models to use in humans. maintenance is not essential for transformation, per se, but
Here we report that primary human fibroblasts can be trans- instead serves as a catalyst of tumorigenic conversion and tu-
mor progression. Mouse models have shown that alterations informed into cancer cells by combined expression of the adeno-
virus E1A, Ha-RasV12, and MDM2. As in previous models of telomere biology may contribute to tumorigenesis in two ways.
We and others have previously reported that telomere shorten-human cell transformation, we make use of a combination of viral
and cellular oncoproteins that act in a transdominant fashion to ing triggers growth arrest and/or apoptosis, as well as chromo-
somal end-to-end fusions, leading to premature aging pheno-alter cellular physiology and achieve tumorigenic growth. In
accord with previous reports, we show that transformation re- types in the context of the telomerase-deficient mice. These
phenotypes can be rescued by telomerase activation (Lee etquires negation of both the Rb and p53 tumor suppressor path-
ways. Through genetic analyses, we have also identified require- al., 1998; Herrera et al., 1999, 2000; Samper et al., 2001). Thus,
telomere shortening during the presumably prolonged coursements for interaction with p300 and p400. Both of these cellular
proteins are also targeted by SV40 large T-antigen, which is a of natural tumor development may antagonize tumorigenesis.
Indeed, Terc/ mice are more resistant to chemical carcinogen-critical element of the transformation model reported by Wein-
berg and colleagues (Hahn et al., 1999; Elenbaas et al., 2001). esis and to spontaneous tumor development in both p16/
p19ARF and APCmin mutant backgrounds (Greenberg et al.,However, recent reports suggest that these are not critical func-
tions of large T, at least in the presence of small t-antigen (Hahn 1999; Gonza´lez-Sua´rez et al., 2000; Rudolph et al., 2001). How-
ever, exhausted telomeres can also compromise chromosomeet al., 2002).
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Cells infected at passage 16 were injected at passage 25 and 30, while cellsintegrity. In fact, in a p53/ background, Terc/ mice show
infected at passage 22 were injected at passage 25 and 33.higher levels of chromosomal instability and a higher incidence
WI-38 are normal embryonic lung fibroblasts (ATCC catalog CCL-75).of cancer, suggesting that telomere depletion can actually act
These cells have a finite lifespan of 50 	 10 PD and were provided by ATCC
as a prooncogenic factor under certain conditions (Chin et al., at PD24. These cells were infected at passage 6 and 10 and injected into
1999). mice at passage 14, 15, and 18.
Detroit 551 are normal human fetal fibroblasts (ATCC catalog CCL-110)The data presented here suggest that, while changes in
provided by ATCC around PD 10 and reported to have a finite lifespan oftelomere biology are very likely to be important for the course
25 additional serial passages. These cells were infected at passage 6 andof natural tumor development, telomere maintenance is not an
10 and injected into mice at passage 14–15 and 18.
absolute requirement for the creation of human cancer cells by HSF43 are normal human foreskin fibroblasts originally isolated at the
acute alteration of oncogenes and tumor suppressors. Rather, Los Alamos National Laboratory. The original PD of these cells was unknown
in our human transformation model, the activation of telomere but in our hands they cease proliferation after 40–50 passages. These cells
were infected at passage 17 and 20 and injected at passage 24 and 27.maintenance strategies becomes important only during pro-
HS68 are normal human foreskin fibroblasts (ATCC catalog CRL-1635)longed expansion of tumor cells to restore genomic stability to
that were received from ATCC at PD 16. These cells can be propagated foran extent that permits cell survival. Our data are in agreement
40–50 passages. They were infected at passage 11 and 17.
with observations in a number of human cancers where the HMSC 7214 are normal human mesenchymal stem cells obtained from
frequency and intensity of telomerase activation correlates with Poietics-Biowhittaker at passage 2 (catalog PT-2501). They were derived
tumor grade/stage (Chadeneau et al., 1995; Hiyama et al., 1995; from a 19-year-old Caucasian male and their lifespan has not been deter-
mined. These cells were infected at passage 6.Albanell et al., 1997; Tang et al., 1998; Ebina et al., 1999; Yan
et al., 1999). Indeed, our ERM system can be considered as a
Cell culture conditionshuman complement to a mouse model recently developed by
BJ normal human foreskin fibroblasts were maintained in minimum essential
DePinho and colleagues. They have shown that the absence of medium with Earle’s salts (MEM) supplemented with nonessential amino
telomerase in Terc/Apcmin mice increases the frequency of acids (NEAA) and 10% fetal bovine serum (FBS) (Gibco BRL). 293T, Detroit
early stage intestinal adenomas but decreases the multiplicity 551, WI-38, HSF43, and SF68 cells were maintained in Dulbecco’s modified
Eagle culture medium (DMEM), supplemented with 0.01% sodium pyruvateand size of later stage lesions. They further suggest that chromo-
and 10% FBS. The same lot of serum was used throughout the experiments.some instability arising from telomere depletion may promote
HMSC human primary mesodermal cells (Poietics, BioWhittaker) were grownearly stage carcinogenesis, but that acquisition of telomere
in MSCGM synthetic medium (Poietics, BioWhittaker). All cells were cultured
maintenance strategies is important for tumor progression (Ru- at 37
C in the presence of 5% CO2. All human primary fibroblasts were
dolph et al., 2001). maintained at a subcultivation ratio of 1:2 every 3 days.
Using oncoprotein mutants and genetic complementation,
Retroviral infectionwe find that inactivation of the Rb and p53 tumor suppressor
pBABE-Puro Ha-rasV12, Wzl-Neo E1A 12s, pHygroMaRX mdm2, and corre-pathways is critical for this transformation process. Further-
sponding empty retroviral vectors were used to singularly transfect the am-more, we find that the ability of E1A to target p300 and p400
photropic packaging cell line LinX-A (Hannon et al., 1999). Transfection was
is essential for its ability to function as a human oncogene. It performed by the calcium phosphate method. At 72 hr posttransfection,
will also be of interest to determine whether MDM2 contributes viral supernatants were collected, filtered, supplemented with 4 g/ml poly-
to the transformation of human cells solely through its ability brene, and combined in order to obtain the oncogene combinations de-
scribed in the text. In cells where only one or two oncogenes were used toto antagonize p53 or also via effects on additional cellular path-
infect the primary cells, corresponding empty vectors replaced the omittedways.
oncogenes so that infected cells were equally resistant to all the selectionThe war on cancer is predicated on the notion that increased
drugs used (hygromycin, puromycin, and neomycin). The proper viral mix
understanding of the biology of cancer cells might reveal an was then used to infect human primary fibroblasts (BJ, Detroit 551, WI-38,
“Achilles heel” that can be exploited as an effective and specific HSF43, SF68) and human primary mesodermal cells (HMSC). After infection,
therapeutic target. The use of rodent cell culture and of animal cells were selected with a combination of hygromycin (50 g/ml), puromycin
(1 g/ml), and neomycin (300 g/ml) for 7 days. Effective infection wasmodels have been the most informative vehicles in the drive
confirmed by Western blot analysis.toward this goal. However, the availability of defined human cell
transformation models will allow us to build toward a complete
Western blot analysis
understanding of the biological pathways that must be altered Western blotting was performed essentially as described by Harlow and
to achieve tumorigenic conversion of normal cells. Lane (1999). Cells were washed with cold PBS and lysed in Laemmli loading
buffer. Lysates were heated at 95
C for 10 min. Samples were separated on
Experimental procedures 10% SDS-polyacrylamide gels and transferred to nitrocellulose membranes
(Schleicher & Schuell). Blots were incubated with the following mouse mono-
Cells clonal antibodies: E1A-specific M58 and M73 antibody—the latter recog-
The following human primary cells were used for the experiments described nizes an epitope retained in all E1A mutants studied (Samuelson and Lowe,
in the text. We defined passage number 1 as the passage at which the cells 1997); c-Ha-ras (OP23) (Oncogene Research Products); mdm2-spcific anti-
were provided from ATCC. All the cells were maintained at a subcultivation body (4B2) (a kind gift from A. Levine); bcl2 (C2) (Santa Cruz); p53 (DO-1)
ratio of 1:2 every 3 days. (Santa Cruz). Immune complexes were visualized by secondary incubation
BJ are normal human foreskin fibroblasts (ATCC catalog CRL-2522). with a sheep anti-mouse HRP-conjugated secondary antibody (Amersham).
They were provided by ATCC at population doubling 22 and are described Blots were developed by enhanced chemiluminescence (Amersham).
to have the capacity to reach 80 	 10 PD. In our hands, these cells cease
proliferation at around passage 45. Most of the experiments described in Anchorage-independent growth
the text were done using BJ infected at passage 16 and injected at passages Human primary fibroblasts uninfected, infected with a control empty virus,
20, 25, and 30. However, experiments were also performed at earlier and or expressing different oncogenes (E1A, Ha-rasV12, mdm2), alone or in
later passages. In particular, BJ cells were infected at passage 8, 16, and combination, were analyzed for anchorage-independent growth in semisolid
media. Approximately 105 cells were plated in 0.3% low melting point aga-22. Cells infected at passage 8 were injected into mice at passage 12 and 20.
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rose/growth media onto 60 mm dishes with a 0.5% agarose underlay. Fresh Images were captured using Leica Q-FISH software at 400 mSec inte-
top agar was added weekly. Colonies were photographed after 2 weeks. gration-time in a linear acquisition mode to prevent oversaturation of fluo-
rescence intensity and recorded using a COHU CCD camera on a Leica
Leitz DMRB fluorescence microscope.Subcutaneous tumorigenicity assay
For the tumorigenicity assays, eight-week-old immunocompromised TFL-Telo software (gift from Dr. Lansdorp, Vancouver) was used to
athymic nude mice (Hsd:Athymic nude-nu, Harlan) were used. Cells (5  quantify the fluorescence intensity of telomeres from at least 10 metaphases
106 ) were resuspended in 100 l of PBS and injected with a 25 gauge needle of each data point. The images of metaphases from different cell cultures
into anaesthetized mice. were captured on the same day in parallel, and scored blind.
BJ cells infected with the E1A/ras combination were also injected into Terminal restriction fragment analysis (TRF)
10 nude mice -irradiated with 400 rad prior injection and into 6 SCID beige Cells were prepared in agarose plugs and digested with Mbo I for TRF
mice (C.B-17/lcrHsd-scid-bg, Harlan). Tumor size was monitored every 5 analysis using pulse-field electrophoresis as described in Blasco et al.
days. Mice were sacrificed when the tumors reached a diameter of 1–1.2 (1997b).
cm or after 16 weeks of monitoring. Telomerase assays
Tumors were collected in a sterile field and minced. Tumor fragments Telomerase activity was measured with a modified telomeric repeat amplifi-
were immediately frozen in liquid nitrogen for DNA and protein extraction cation protocol (TRAP), as described (Blasco et al., 1997b).
and for telomerase assays. Other fragments were fixed in 10% formalin for
histological and immunohistochemical examinations. Finally, fragments were Analysis of hTERT mRNA expression by RT-PCR
finely minced, washed in PBS, and plated in culture medium for isolation of Analysis of human TERT expression was carried out by RT-PCR. cDNA was
tumor cells. synthesized from 1 g of total RNA using random primers in a 20 l reaction.
1 l of cDNA was then used to amplify two fragments of human TERT
Tumor morphological and histochemical examination sequence, both spanning an intronic sequence. Primers hTERT1s, 5-TTCCT
Formalin-fixed/paraffin-embedded or snap-frozen fragments of tumor speci- GCACTGGCTGATGAGTGT-3 and hTERT1a, 5-AGCGTCGGCCCTCTTTTC
mens were stained with hematoxylin and eosin and with histochemical stains TCTG-3 were used to amplify a 330 bp fragment spanning exons 3 and 4
(PAS and PAS after diastase, Reticulum, and Masson’s trichrome stain) for of the human TERT sequence. Primers hTERT2s, 5-ACAGCACTTGAA
morphological evaluation and histochemical analyses. Immunohistochemis- GAGGGTG-3 and hTERT2a, 5-GTGCCTTCACCCTCGAGG-3 were used
try was performed with the peroxidase ARK kit (DAKO Glostrup Denmark) to amplify a 210 bp fragment spanning exons 4 and 5 of the human TERT
and DAB as chromogen. The following primary antibodies were utilized: sequence. Both PCR reactions were carried out for 40 or 50 cycles with an
Intermediate filaments (Vimentin, pan-keratin, desmin) and other human spe- elongation at 72
C for 30 s and annealing at 65
C. PCR products were
cific monoclonal antibodies (S100 protein, EMA, CD45) were used as histo- analyzed on a 3% agarose gel. The quality of cDNA was controlled by PCR
genetic markers. The expression of ectopically expressed oncogenes was amplification of a 500 bp fragment of a -actin transcript in a 20 cycle-PCR
determined by using monoclonal antibodies specific for MDM2 (4B2) (a kind reaction.
gift from A. Levine), p21-ras (OP23) (Oncogene Research Products), and
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